USAEUROPEViVE
ABOUTSPONSORSHIPFOUNDATION
Logo Hlth
Logo Hlth
12 Oct 2021 | 02:45 PM GMT

DTx - Pharma partnerships

Anchored by:

Rick Bartels
President/Founder
DTXCC

Participants:

Rick Bartels President/Founder DTxCC
Rick Bartels
President/Founder DTxCC
Abhishek Shah Co-Founder & CEOWellthy Therapeutics Pvt. Ltd.
Abhishek Shah
Co-Founder & CEOWellthy Therapeutics Pvt. Ltd.
Anish Shindore Founder & Managing PartnerGSD Health
Anish Shindore
Founder & Managing PartnerGSD Health
AC
Arnab Chakrabarty Medical AffairsKyowa Kirin
AC
Arnab Chakrabarty
Medical AffairsKyowa Kirin
Chris Cera CEOArcweb Technologies
Chris Cera
CEOArcweb Technologies
Gaurav Shah Senior DirectorSanofi
Gaurav Shah
Senior DirectorSanofi
Matt Norton VP of Marketing & Commercial DevelopmentS3 Connected Health
Matt Norton
VP of Marketing & Commercial DevelopmentS3 Connected Health
Reginald Swift Founder & CEORubix LS
Reginald Swift
Founder & CEORubix LS
Zar Salih Business Development ExecutiveClosed Loop Medicine
Zar Salih
Business Development ExecutiveClosed Loop Medicine

About this Meeting

Pharma companies are accelerating their incorporation of digital tools across all aspects of their business with Digital Therapeutics (DTx) being an element of this digital transformation. However, what DTx means in practice for Pharma companies is still primarily pilots as companies grapple to see how to monetize DTx in a traditional pharma business. Join us in this informal conversation with other senior leaders where we will talk about: 

  •  Drivers for both DTx and pharma companies for partnering up 
  •  How to monetize DTx in a traditional pharma business (ROI)? 
  •  Most pharma-DTx collaborations have been companion-style DTx as opposed to standalone therapies; will this change in the next few years?  
  •  From an organizational perspective, what are the key changes pharma needs to do to successfully integrate DTx in their business model?